Reply
Femke H.C. Goeij, Andrea Schlegel, Philipp Dutkowski – 7 October 2021
Seroconversion After Coronavirus Disease 2019 Vaccination
Pathum Sookaromdee, Viroj Wiwanitkit – 6 October 2021
Introduction of the Concept of Diagnostic Sensitivity and Specificity of Normothermic Perfusion Protocols to Assess High‐Risk Donor Livers
Hynek Mergental, Richard W. Laing, James Hodson, Yuri L. Boteon, Joseph A. Attard, Laine L. Walace, Desley A. H. Neil, Darren Barton, Andrea Schlegel, Paolo Muiesan, Manuel Abradelo, John R. Isaac, Keith Roberts, M. Thamara P. R. Perera, Simon C. Afford, Darius F. Mirza – 6 October 2021 – Normothermic machine perfusion (NMP) allows objective assessment of donor liver transplantability. Several viability evaluation protocols have been established, consisting of parameters such as perfusate lactate clearance, pH, transaminase levels, and the production and composition of bile.
GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis
Amit G. Singal, Nabihah Tayob, Anand Mehta, Jorge A. Marrero, Hashem El‐Serag, Qingchun Jin, Cristian Saenz de Viteri, Austin Fobar, Neehar D. Parikh – 6 October 2021
Reply
Alberto Calleri, Margherita Saracco, Fabrizia Pittaluga, Rossana Cavallo, Renato Romagnoli, Silvia Martini – 6 October 2021
Redefining Success After Liver Transplantation: From Mortality Toward Function and Fulfillment
Marina Serper, Sumeet Asrani, Lisa VanWagner, Peter P. Reese, Minjee Kim, Michael S. Wolf – 4 October 2021 – Liver transplantation (LT), the only cure for end‐stage liver disease, is a lifesaving, costly, and limited resource. LT recipients (LTRs) are aging with an increasing burden of medical comorbidities. Patient and graft survival rates exceed 70% at 5 years; however, patient‐centered health outcomes beyond survival have received relatively little attention.
Assessment of Deceased Brain Dead Donor Liver Grafts via Normothermic Machine Perfusion: Lactate Clearance Time Threshold Can Be Safely Extended to 6 Hours
Angus Hann, Hanns Lembach, Anisa Nutu, Hynek Mergental, John L. Isaac, John R. Isaac, Ye H. Oo, Matthew J. Armstrong, Neil Rajoriya, Simon Afford, David Bartlett, Darius F. Mirza, Hermien Hartog, M. Thamara P.R. Perera – 3 October 2021
MicroRNA‐206 enhances antitumor immunity by disrupting the communication between malignant hepatocytes and regulatory T cells in c‐Myc mice
Ningning Liu, Clifford J. Steer, Guisheng Song – 3 October 2021
BMS‐986263 in patients with advanced hepatic fibrosis: 36‐week results from a randomized, placebo‐controlled phase 2 trial
Eric J. Lawitz, Diane E. Shevell, Giridhar S. Tirucherai, Shuyan Du, Warner Chen, Uma Kavita, Angie Coste, Fred Poordad, Morten Karsdal, Mette Nielsen, Zachary Goodman, Edgar D. Charles – 3 October 2021
E. coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinants
Yao Yang, Jinjung Choi, Ying Chen, Pietro Invernizzi, Guoxiang Yang, Weici Zhang, Ti‐hong Shao, Frank Jordan, Natalia S. Nemeria, Ross L. Coppel, William M. Ridgway, Mark Kurth, Aftab A. Ansari, Patrick S.C. Leung, M. Eric Gershwin – 3 October 2021